Risk Adapted Therapy in Diffuse Large B Cell Lymphoma

Clinical trial NCT03188198 · UNKNOWN

Trial details

NCT number: NCT03188198
Sponsor: Mansoura University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Large B Cell Lymphoma

Start date: 2016-06-01
Primary completion: 2018-06-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.